Liver abscess in advanced hepatocellular carcinoma after sorafenib treatment.

Seung Kak Shin, Young Kul Jung, Hyun Hwa Yoon, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an advanced stage and their tumors are unresectable. Sorafenib is a multi-kinase inhibitor of the vascular endothelial growth factor pathway and was recently introduced as a therapy for advanced HCC. Furthermore, studies have shown that oral sorafenib has beneficial effects on survival. However, many patients experience diverse side effects, and some of these are severe. Liver abscess development has not been previously documented to be associated with sorafenib administration in HCC. Here, we report the case of a HCC patient that developed a liver abscess while being treated with sorafenib.

Original languageEnglish
Pages (from-to)47-50
Number of pages4
JournalThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Volume63
Issue number1
Publication statusPublished - 2014 Jan 1
Externally publishedYes

Fingerprint

Liver Abscess
Hepatocellular Carcinoma
Therapeutics
Vascular Endothelial Growth Factor A
Neoplasms
Phosphotransferases
sorafenib
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Liver abscess in advanced hepatocellular carcinoma after sorafenib treatment. / Shin, Seung Kak; Jung, Young Kul; Yoon, Hyun Hwa; Kwon, Oh Sang; Kim, Yun Soo; Choi, Duck Joo; Kim, Ju Hyun.

In: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, Vol. 63, No. 1, 01.01.2014, p. 47-50.

Research output: Contribution to journalArticle

Shin, Seung Kak ; Jung, Young Kul ; Yoon, Hyun Hwa ; Kwon, Oh Sang ; Kim, Yun Soo ; Choi, Duck Joo ; Kim, Ju Hyun. / Liver abscess in advanced hepatocellular carcinoma after sorafenib treatment. In: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2014 ; Vol. 63, No. 1. pp. 47-50.
@article{07e93077c8b742bda537508cc009812d,
title = "Liver abscess in advanced hepatocellular carcinoma after sorafenib treatment.",
abstract = "Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an advanced stage and their tumors are unresectable. Sorafenib is a multi-kinase inhibitor of the vascular endothelial growth factor pathway and was recently introduced as a therapy for advanced HCC. Furthermore, studies have shown that oral sorafenib has beneficial effects on survival. However, many patients experience diverse side effects, and some of these are severe. Liver abscess development has not been previously documented to be associated with sorafenib administration in HCC. Here, we report the case of a HCC patient that developed a liver abscess while being treated with sorafenib.",
author = "Shin, {Seung Kak} and Jung, {Young Kul} and Yoon, {Hyun Hwa} and Kwon, {Oh Sang} and Kim, {Yun Soo} and Choi, {Duck Joo} and Kim, {Ju Hyun}",
year = "2014",
month = "1",
day = "1",
language = "English",
volume = "63",
pages = "47--50",
journal = "The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi",
issn = "1598-9992",
publisher = "Korean Society of Gastroenterology",
number = "1",

}

TY - JOUR

T1 - Liver abscess in advanced hepatocellular carcinoma after sorafenib treatment.

AU - Shin, Seung Kak

AU - Jung, Young Kul

AU - Yoon, Hyun Hwa

AU - Kwon, Oh Sang

AU - Kim, Yun Soo

AU - Choi, Duck Joo

AU - Kim, Ju Hyun

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an advanced stage and their tumors are unresectable. Sorafenib is a multi-kinase inhibitor of the vascular endothelial growth factor pathway and was recently introduced as a therapy for advanced HCC. Furthermore, studies have shown that oral sorafenib has beneficial effects on survival. However, many patients experience diverse side effects, and some of these are severe. Liver abscess development has not been previously documented to be associated with sorafenib administration in HCC. Here, we report the case of a HCC patient that developed a liver abscess while being treated with sorafenib.

AB - Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an advanced stage and their tumors are unresectable. Sorafenib is a multi-kinase inhibitor of the vascular endothelial growth factor pathway and was recently introduced as a therapy for advanced HCC. Furthermore, studies have shown that oral sorafenib has beneficial effects on survival. However, many patients experience diverse side effects, and some of these are severe. Liver abscess development has not been previously documented to be associated with sorafenib administration in HCC. Here, we report the case of a HCC patient that developed a liver abscess while being treated with sorafenib.

UR - http://www.scopus.com/inward/record.url?scp=84903764741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903764741&partnerID=8YFLogxK

M3 - Article

C2 - 24463289

AN - SCOPUS:84903764741

VL - 63

SP - 47

EP - 50

JO - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

JF - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

SN - 1598-9992

IS - 1

ER -